ID

13568

Descripción

Phase 1 clinical trial for intrasurgical hyperthermic intraperitoneal chemoperfusion with cisplatin (HIPEC) in patients with ovarian cancer recidiv EudraCT Nr.: 2010-024352-28 Principal investigator und authorized representative of Sponsor: PD Dr. med. Oliver Zivanovic Center for Obstetrics and Gynaecology University Hospital Bonn Sigmund-Freud-Str. 25 53105 Bonn Sponsor: Rheinische Friedrich-Wilhelms-Universität Bonn represented by the Dean of Medical Faculty

Palabras clave

  1. 16/2/16 16/2/16 -
Subido en

16 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Visit 9 Phase 1 clinical trial for intrasurgical hyperthermic intraperitoneal chemoperfusion with cisplatin (HIPEC) in patients with ovarian cancer recidiv

Case Report Form (HIPEC) Visit 9

Visit 9: First cycle of post-OP Chemotherapy
Descripción

Visit 9: First cycle of post-OP Chemotherapy

Patient ID
Descripción

Patient ID

Tipo de datos

integer

Alias
UMLS CUI [1]
C1269815
CRF number
Descripción

CRF number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1516308
UMLS CUI [1,2]
C0449788
Date of visit
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Status of Patient and recording of CTCAE
Descripción

Status of Patient and recording of CTCAE

Has patient appeared for the planned visit?
Descripción

Patient Visit

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1512346
If patient didn´t come for the scheduled visit, please call the patient and try to verify the reason why.
Descripción

Patient visit

Tipo de datos

text

Alias
UMLS CUI [1]
C1512346
Has the Patient deceased?
Descripción

Patient deceased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1555024
Please specify the date the patient died
Descripción

Date of death

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0011065
Has a progressive disease been diagnosed?
Descripción

Progressive disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1335499
Please give the date, the progression was diagnosed
Descripción

Progressive Disease date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1335499
UMLS CUI [1,2]
C0011008
Recurrent Disease
Descripción

Relapse

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0277556
Please give the date, the relapse was diagnosed
Descripción

Date of relapse

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C0011008
Recording of CTCAE: Have any AE occurred since the last Visit? If `Yes` please fill in AE-Form
Descripción

CTCAE

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1516728
Postoperative chemotherapy
Descripción

Postoperative chemotherapy

Postoperative chemotherapy will be administered
Descripción

Postoperative chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032790
UMLS CUI [1,2]
C0392920
Please specify the reason why, if chemotherapy will not be administered
Descripción

Postoperative chemotherapy

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0032790
UMLS CUI [1,2]
C0392920
If chemotherapy will be administered, please specify the nature of the planned regimen
Descripción

Postoperative chemotherapy

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0032790
UMLS CUI [1,2]
C0392920
Please specify the agent used for chemotherapy
Descripción

Postoperative chemotherapy

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0032790
UMLS CUI [1,2]
C0392920
Please specify other chemotherapeutic agent used
Descripción

Other antineoplastic agent

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0205394
Dose of Carboplatin administerd
Descripción

Carboplatin

Tipo de datos

float

Unidades de medida
  • AUC
Alias
UMLS CUI [1]
C0079083
AUC
Dose of Paclitaxel administered
Descripción

Paclitaxel

Tipo de datos

float

Unidades de medida
  • mg/m2
Alias
UMLS CUI [1]
C0144576
mg/m2
Dose of Gemcitabine administered
Descripción

Gemcitabine

Tipo de datos

float

Unidades de medida
  • mg/m2
Alias
UMLS CUI [1]
C0045093
mg/m2
Dose of Doxorubicin liposome administered
Descripción

Doxorubicin liposome

Tipo de datos

float

Unidades de medida
  • mg/m2
Alias
UMLS CUI [1]
C0717726
mg/m2
Dose of other antineoplastic agent administered
Descripción

Other antineoplastic agent

Tipo de datos

float

Unidades de medida
  • mg/m2
Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0205394
mg/m2
Course of chemotherapy cycle
Descripción

Course of chemotherapy cycle

Date of first chemotherapy
Descripción

Date of first chemotherapy

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0392920
Total dose of Carboplatin administered
Descripción

Total dose of antineoplastic agent

Tipo de datos

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0178602
mg
Has the dose been modified?
Descripción

Dose modification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707811
Please specify what kind of dose modification was used
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Please specify the reason for the dose modification
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Total dose of Paclitaxel administered
Descripción

Total dose of antineoplastic agent

Tipo de datos

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0178602
mg
Has the dose been modified?
Descripción

Dose modification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707811
Please specify what kind of dose modification was used
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Please specify the reason for the dose modification
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Total dose of Gemcitabine administered
Descripción

Total dose of antineoplastic agent

Tipo de datos

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0178602
mg
Has the dose been modified?
Descripción

Dose modification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707811
Please specify what kind of dose modification was used
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Please specify the reason for the dose modification
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Total dose of doxorubicin liposome administered
Descripción

Total dose of antineoplastic agent

Tipo de datos

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0178602
mg
Has the dose been modified?
Descripción

Dose modification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707811
Please specify what kind of dose modification has been used
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Please specify the reason for the dose modification
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Total dose of other chemotherapeutic agent administered
Descripción

Total dose of antineoplastic agent

Tipo de datos

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0178602
mg
Has the dose been modified?
Descripción

Dose modification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707811
Please specify what kind of dose modification has been used
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Please specify the reason for the dose modification
Descripción

Dose modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Any further oncologic treatments?
Descripción

Further antineoplastic treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C1517331
Please specify any further antineoplastic treatments that have been carried out.
Descripción

Further antineoplastic treatment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C1517331
Confirmation of correctness
Descripción

Confirmation of correctness

Name of Investigator
Descripción

Name of Investigator

Tipo de datos

text

Alias
UMLS CUI [1]
C0008961
Signature by investigator: I personally controlled all entries into this form for this patient. All data and statements in this CRF are complete and correct
Descripción

Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C1519316
Date of completion of this form
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008

Similar models

Case Report Form (HIPEC) Visit 9

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Visit 9: First cycle of post-OP Chemotherapy
Patient ID
Item
Patient ID
integer
C1269815 (UMLS CUI [1])
CRF number
Item
CRF number
integer
C1516308 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
Date
Item
Date of visit
date
C0011008 (UMLS CUI [1])
Item Group
Status of Patient and recording of CTCAE
Patient Visit
Item
Has patient appeared for the planned visit?
boolean
C1512346 (UMLS CUI [1])
Patient visit
Item
If patient didn´t come for the scheduled visit, please call the patient and try to verify the reason why.
text
C1512346 (UMLS CUI [1])
Patient deceased
Item
Has the Patient deceased?
boolean
C1555024 (UMLS CUI [1])
Date of death
Item
Please specify the date the patient died
date
C0011008 (UMLS CUI [1,1])
C0011065 (UMLS CUI [1,2])
Progressive disease
Item
Has a progressive disease been diagnosed?
boolean
C1335499 (UMLS CUI [1])
Progressive Disease date
Item
Please give the date, the progression was diagnosed
date
C1335499 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Relapse
Item
Recurrent Disease
boolean
C0277556 (UMLS CUI [1])
Date of relapse
Item
Please give the date, the relapse was diagnosed
boolean
C0035020 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
CTCAE
Item
Recording of CTCAE: Have any AE occurred since the last Visit? If `Yes` please fill in AE-Form
boolean
C1516728 (UMLS CUI [1])
Item Group
Postoperative chemotherapy
Postoperative chemotherapy
Item
Postoperative chemotherapy will be administered
boolean
C0032790 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Postoperative chemotherapy
Item
Please specify the reason why, if chemotherapy will not be administered
text
C0032790 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Item
If chemotherapy will be administered, please specify the nature of the planned regimen
text
C0032790 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Code List
If chemotherapy will be administered, please specify the nature of the planned regimen
CL Item
monotherapy (1)
CL Item
combination therapy (2)
Item
Please specify the agent used for chemotherapy
text
C0032790 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Code List
Please specify the agent used for chemotherapy
CL Item
Carboplatin (1)
CL Item
Paclitaxel (2)
CL Item
Gemcitabine (used on first or eighth day of cycle) (3)
CL Item
Doxorubicin liposome (4)
CL Item
other (5)
Other antineoplastic agent
Item
Please specify other chemotherapeutic agent used
text
C0003392 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Carboplatin
Item
Dose of Carboplatin administerd
float
C0079083 (UMLS CUI [1])
Paclitaxel
Item
Dose of Paclitaxel administered
float
C0144576 (UMLS CUI [1])
Gemcitabine
Item
Dose of Gemcitabine administered
float
C0045093 (UMLS CUI [1])
Doxorubicin liposome
Item
Dose of Doxorubicin liposome administered
float
C0717726 (UMLS CUI [1])
Other antineoplastic agent
Item
Dose of other antineoplastic agent administered
float
C0003392 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Course of chemotherapy cycle
Date of first chemotherapy
Item
Date of first chemotherapy
date
C0011008 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Total dose of antineoplastic agent
Item
Total dose of Carboplatin administered
integer
C0003392 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dose modification
Item
Has the dose been modified?
boolean
C1707811 (UMLS CUI [1])
Item
Please specify what kind of dose modification was used
text
C1707811 (UMLS CUI [1])
Code List
Please specify what kind of dose modification was used
CL Item
Dose reduction (1)
CL Item
Delay/Deceleration (2)
CL Item
Discontinuation (3)
Item
Please specify the reason for the dose modification
text
C1707811 (UMLS CUI [1])
Code List
Please specify the reason for the dose modification
CL Item
hematologic toxicitiy (1)
CL Item
hypersensitivity (2)
CL Item
other (3)
Total dose of antineoplastic agent
Item
Total dose of Paclitaxel administered
integer
C0003392 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dose modification
Item
Has the dose been modified?
boolean
C1707811 (UMLS CUI [1])
Item
Please specify what kind of dose modification was used
text
C1707811 (UMLS CUI [1])
Code List
Please specify what kind of dose modification was used
CL Item
Dose reduction (1)
CL Item
Delay/Deceleration (2)
CL Item
Discontinuation (3)
Item
Please specify the reason for the dose modification
text
C1707811 (UMLS CUI [1])
Code List
Please specify the reason for the dose modification
CL Item
hematologic toxicity (1)
CL Item
hypersensitivity (2)
CL Item
other (3)
Total dose of antineoplastic agent
Item
Total dose of Gemcitabine administered
integer
C0003392 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dose modification
Item
Has the dose been modified?
boolean
C1707811 (UMLS CUI [1])
Item
Please specify what kind of dose modification was used
text
C1707811 (UMLS CUI [1])
Code List
Please specify what kind of dose modification was used
CL Item
Dose reduction  (1)
CL Item
Delay/Deceleration  (2)
CL Item
Discontinuation (3)
Item
Please specify the reason for the dose modification
text
C1707811 (UMLS CUI [1])
Code List
Please specify the reason for the dose modification
CL Item
hematologic toxicity  (1)
CL Item
hypersensitivity  (2)
CL Item
other (3)
Total dose of antineoplastic agent
Item
Total dose of doxorubicin liposome administered
integer
C0003392 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dose modification
Item
Has the dose been modified?
boolean
C1707811 (UMLS CUI [1])
Item
Please specify what kind of dose modification has been used
text
C1707811 (UMLS CUI [1])
Code List
Please specify what kind of dose modification has been used
CL Item
Dose reduction (1)
CL Item
Delay/Deceleration (2)
CL Item
Discontinuation (3)
Item
Please specify the reason for the dose modification
text
C1707811 (UMLS CUI [1])
Code List
Please specify the reason for the dose modification
CL Item
hematologic toxicity  (1)
CL Item
hypersensitivity  (2)
CL Item
other (3)
Total dose of antineoplastic agent
Item
Total dose of other chemotherapeutic agent administered
integer
C0003392 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dose modification
Item
Has the dose been modified?
boolean
C1707811 (UMLS CUI [1])
Item
Please specify what kind of dose modification has been used
text
C1707811 (UMLS CUI [1])
Code List
Please specify what kind of dose modification has been used
CL Item
Dose reduction  (1)
CL Item
Delay/Deceleration  (2)
CL Item
Discontinuation (3)
Item
Please specify the reason for the dose modification
text
C1707811 (UMLS CUI [1])
Code List
Please specify the reason for the dose modification
CL Item
hematologic toxicity  (1)
CL Item
hypersensitivity  (2)
CL Item
other (3)
Further antineoplastic treatment
Item
Any further oncologic treatments?
boolean
C0920425 (UMLS CUI [1,1])
C1517331 (UMLS CUI [1,2])
Further antineoplastic treatment
Item
Please specify any further antineoplastic treatments that have been carried out.
text
C0920425 (UMLS CUI [1,1])
C1517331 (UMLS CUI [1,2])
Item Group
Confirmation of correctness
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI [1])
Signature
Item
Signature by investigator: I personally controlled all entries into this form for this patient. All data and statements in this CRF are complete and correct
text
C1519316 (UMLS CUI [1])
Date
Item
Date of completion of this form
date
C0011008 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial